Stockreport

VarmX Partners With CSL in a Strategic Collaboration and Option Agreement to Develop Novel Investigational Coagulation Treatment [Yahoo! Finance]

CSL LTD SP/ADR  (CSLLY) 
NASDAQ:AMEX Investor Relations: csl.com/investors
PDF VarmX shareholders to receive initial $117m upfront and further potential milestone payments up to $2.1bn Transformational step for VarmX, well positioned to bring VM [Read more]